好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Loss of intrathalamic tissue integrity in pediatric-onset multiple sclerosis measured with DTI.
Multiple Sclerosis
P5 - Poster Session 5 (5:30 PM-6:30 PM)
15-039

To determine whether intrathalamic tissue integrity measured using diffusion tensor imaging (DTI) is impaired early in the disease in a cohort of pediatric-onset MS patients imaged prior to cognitive and physical impairment.

The thalamus is composed of multiple regions, each with connections to cortical and subcortical areas that serve specific functions. Prominent thalamic volume loss has been reported in pediatric-onset MS (POMS). However, intra-thalamic tissue integrity has not been studied. 

64 direction DTI scans collected at York University using a 3T scanner with 32 channel head coil, were analyzed from 31 healthy controls (mean age=18 yrs, SD=3; 25 females) and 23 pediatric-onset MS patients (mean age=18 yrs, SD=3; 17 females, median EDSS 1.5, range 1-6). Mean fractional anisotropy (FA), mean and radial diffusivity (MD and RD) values were extracted from seven thalamic connectivity based regions - primary motor, sensory, occipital, prefrontal, premotor, posterior parietal, temporal and whole thalamus (identified using Oxford thalamic connectivity atlas) and compared between groups.

Whole-thalamus MD was significantly reduced in MS (p < 0.0005) while FA was modestly reduced in MS compared to healthy controls (p = 0.06). Of the regions analyzed, FA was reduced in the occipital and temporal connectivity regions in MS patients (p < 0.0005). MD and RD of the occipital, posterior-parietal, temporal (p < 0.0005 uncorrected) and pre-frontal (p < 0.001) regions were increased in the MS group. Total normalized thalamic volume was smaller in MS patients (p < 0.0005) but total brain volume did not differ between the groups. 

Intrathalamic tissue is compromised in pediatric-onset MS, supporting loss of thalamic structural integrity as an early aspect of MS pathobiology. Further studies will evaluate thalamocortical tracts to define their relationships with thalamic integrity and cognitive and clinical outcomes. 

Authors/Disclosures

PRESENTER
No disclosure on file
Christine Till, PhD (York University) No disclosure on file
No disclosure on file
No disclosure on file
Nadine Akbar (Sunnybrook Health Sciences Centre) No disclosure on file
Sudipto Dolui, PhD (University of Pennsylvania) Dr. Dolui has nothing to disclose.
Sridar Narayanan (Montreal Neurological Institute) Sridar Narayanan has received personal compensation for serving as an employee of NeuroRx Research. Sridar Narayanan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech Inc.. The institution of Sridar Narayanan has received research support from Immunotec Inc.
Douglas L. Arnold, MD, FAAN (Montreal Neurological Institute, McGill Univ) Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
E. Ann Yeh, MD, MA, FRCPC (Hospital for Sick Children) Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Brenda L. Banwell, MD, FAAN (Johns Hopkins University) Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.